Single-use Bio processing Systems Market Size to Grow Exponentially through the Assessment Period 2021 2030

In a recent published report, Kenneth Research has updated the market report for Single-use Bio processing Systems Market for 2021 till 2030. Report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In the view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to be regain 25% by the end of 2021- Positive Growth in the economic demand and supply.

U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4  billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Single-use Bio processing Systems Market products.

Request To Download Sample of This Strategic Report:

Kenneth Research has recently added a report titled Single-use Bio processing Systems Market in its storehouse of market research reports. The report provides a detailed insight into the market scenario on the basis of the market size and volume for the forecast period, i.e., 2021 2030. Factors such as the growing advancements in the development of novel drugs, coupled with the growing health infrastructure in several nations worldwide are anticipated to drive the growth of the market in the coming years. Moreover, increasing expenditure on healthcare, backed by the need amongst individuals for quality healthcare services, is also anticipated to contribute to the market growth.

According to the statistics by the World Bank, the current health expenditure (% of GDP) around the world increased from 9.08% in 2001 to 9.84% in 2018. Additionally, the current health expenditure per capita (current US$) increased from USD 492.99 in 2001 to USD 1110.84 in 2018. Moreover, growing concern for deaths caused due to various diseases and the need for treatment that can lower the crude death rate, which in the year 2019 recorded close to 7% (per 1000 people), are also anticipated to drive the market growth during the forecast period.

Bioprocessing is the procedure that includes the utilization of living cells or their components such as the chloroplast, bacteria, and enzymes to meet the product’s desired properties. The single-use bioprocessing systems are the systems which can be disposed of, post its initial use.

Various single-use bioprocessing systems such as media bags and containers, mixers, etc. are disposable after their first use, therefore increasing the chance of eliminating the cost of Clean in Place (CIP) and Sterilize in Place (SIP), which will further help in the growth of efficiency and effectiveness of these systems.

“The Final Report will cover the impact analysis of COVID-19 on this industry.”

Request To Download Sample of This Strategic Report:

At present, leading pharmaceutical companies such as GE Healthcare, Thermo Fisher Scientific Inc and Merck Millipore, etc. are switching to their traditional bioprocessing systems to single-use bioprocessing system for vaccine production, cell therapies, etc. for reducing their incineration costs.

The single-use bioprocessing market is expected to grow at a notable growth rate, primarily owing to rising product adoption in research labs, and various bioprocessing plants, majorly owing to their cost-effectiveness.

Market Dynamics

The adoption of single-use bioprocessing system is largely driven by its capabilities to lower down the risk of contamination. These kinds of risks arise when the same process products are used to manufacture various monoclonal antibodies or proteins.

To avoid this contamination, several additional purification steps needed to be taken which involves a lot of cost and time for the manufacturer. The use of single-use bioprocessing systems is expected to grow, as they can be discarded directly from the flow path, post each batch, which reduces the incineration costs, along with processing times.

Bioprocessing tends to use high pressured equipment in their production flow. As the single-use bioprocessing systems are made of plastic, they are unable to sustain under high pressurized equipment. This might act as a significant restraint for the adoption of single-use bioprocessing systems in the market.

By Product Type

On the basis of product type, the single-use bioprocessing systems are segmented into single-use bioreactors, mixers, fermenters, and others. The bioreactor product segment is anticipated to have a major share over the forecast period owing to its speedy replacements over conventional culture vessels, coupled with adoption of technology in various clinical research and development activities, as this product is largely utilized in the field of mammalian cell cultures coupled with its lower cost of implementation and reduced CIP & SIP.

By Application Type

The single-use bioprocessing systems market is segmented into vaccine production, monoclonal antibody production, patient-specific cell therapies, and others. Monoclonal antibody production is anticipated to hold the prime share in the market owing to its increasing use in various cases such as acute kidney transplant rejection, asthma, leukemia, breast cancer and several others diseases.

By End-use Industry

Biotechnology and pharmaceutical companies end-use industry segment is expected to grab the dominance in the single-use bioprocessing systems market, primarily owing to product’s huge adoption.

Most of the pharmaceutical companies and biotechnology companies are increasing the adoption of single-use bioprocessing systems, primarily owing to the cost reduction of incineration, and also due to their disposable properties. In 2015, 90% of the Biotech and biopharma companies utilized disposable technologies over stainless-steel options owing to its cost and time-saving characteristics, according to BioPan Associates.

Regional Analysis

North America is anticipated to be dominant in the single-use bioprocessing systems market, majorly due to rise in the investment in various R&D activities by biopharmaceutical companies such as Danaher Corporation, GE Healthcare, and Thermo Fisher Scientific Inc.

According to PhRMA, various biopharmaceutical companies in the U.S. had invested approximately US$ 90 billion in 2016 for multiple R&D activities in the U.S. alone. The regional market is further fueled by the increasing adoption of disposable equipment, thus, providing a significant contribution to the market growth.

Read More:-

Key players

The leading players in the market include Pall Corporation, PBS Biotech, Inc., GE Healthcare, Thermo Fisher Scientific, Corning Incorporated and several others. Major players in the market are collaborating to develop advanced technology to grow in the market. For instance, in 2018, a collaboration has been made between Pall Corporation and ARTeSYN Biosolutions to deliver numerous solutions for single use automated bioprocessing systems

About Kenneth Research:-
Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us:-
Name: David
Email : [email protected]
Phone: +1 313 462 0609

 Cell Free DNA Isolation and Extraction Industry
Generic Oncology Drugs Industry Market
Biologics Drug Development Industry Market
Blockchain in the Healthcare Industry Market

Share your love
Christophe Rude

Christophe Rude

Articles: 15892

Leave a Reply

Your email address will not be published. Required fields are marked *